Reshma Rangwala serves as Executive at Karyopharm Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Reshma Rangwala has executed 11 insider transactions totaling $63.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 15, 2025 involved selling 408 shares valued at $2.6K.
Reshma Rangwala currently holds 29,390 shares of Karyopharm Therapeutics Inc. (KPTI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Reshma Rangwala has been a net seller of KPTI stock. They have purchased $0 and sold $63.5K worth of shares.
Reshma Rangwala's most recent insider trade was on Sep 15, 2025, when they sold 408 shares at $6.43 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Apr 22, 2024 | KPTI | $7.9K | Sale | 6,789 | $1.17 | Discretionary |
| Mar 1, 2024 | KPTI | $7.2K | Sale | 5,969 | $1.20 | Discretionary |
| Feb 29, 2024 | KPTI | $18.3K | Sale | 15,667 | $1.17 | Discretionary |
| Feb 28, 2024 | KPTI | $0 | Award | 198,959 | $N/A | Discretionary |
| Jan 24, 2024 | KPTI | $0 | Award | 14,167 | $N/A | Discretionary |
| Apr 20, 2023 | KPTI | $27.0K | Sale | 6,655 | $4.05 | Planned |
| Apr 20, 2023 | KPTI | $463 | Sale | 115 | $4.03 | Planned |
| Feb 28, 2023 | KPTI | $0 | Award | 100,000 | $N/A | Discretionary |
| Apr 29, 2022 | KPTI | $0 | Award | 65,000 | $N/A | Discretionary |